2024-02-012025-01-312025-01-31false04722449WICKHAM MARKET MEDICAL CENTRE LTD.2025-05-01falseiso4217:GBPxbrli:pure047224492024-02-01047224492025-01-31047224492024-02-012025-01-31047224492023-07-01047224492024-01-31047224492023-07-012024-01-3104722449bus:SmallEntities2024-02-012025-01-3104722449bus:AuditExempt-NoAccountantsReport2024-02-012025-01-3104722449bus:AbridgedAccounts2024-02-012025-01-3104722449bus:PrivateLimitedCompanyLtd2024-02-012025-01-3104722449core:WithinOneYear2025-01-3104722449core:AfterOneYear2025-01-3104722449core:WithinOneYear2024-01-3104722449core:AfterOneYear2024-01-3104722449core:ShareCapital2025-01-3104722449core:SharePremium2025-01-3104722449core:RevaluationReserve2025-01-3104722449core:OtherReservesSubtotal2025-01-3104722449core:RetainedEarningsAccumulatedLosses2025-01-3104722449core:ShareCapital2024-01-3104722449core:SharePremium2024-01-3104722449core:RevaluationReserve2024-01-3104722449core:OtherReservesSubtotal2024-01-3104722449core:RetainedEarningsAccumulatedLosses2024-01-3104722449core:LandBuildings2025-01-3104722449core:PlantMachinery2025-01-3104722449core:Vehicles2025-01-3104722449core:FurnitureFittings2025-01-3104722449core:OfficeEquipment2025-01-3104722449core:NetGoodwill2025-01-3104722449core:IntangibleAssetsOtherThanGoodwill2025-01-3104722449core:ListedExchangeTraded2025-01-3104722449core:UnlistedNon-exchangeTraded2025-01-3104722449core:LandBuildings2024-01-3104722449core:PlantMachinery2024-01-3104722449core:Vehicles2024-01-3104722449core:FurnitureFittings2024-01-3104722449core:OfficeEquipment2024-01-3104722449core:NetGoodwill2024-01-3104722449core:IntangibleAssetsOtherThanGoodwill2024-01-3104722449core:ListedExchangeTraded2024-01-3104722449core:UnlistedNon-exchangeTraded2024-01-3104722449core:LandBuildings2024-02-012025-01-3104722449core:PlantMachinery2024-02-012025-01-3104722449core:Vehicles2024-02-012025-01-3104722449core:FurnitureFittings2024-02-012025-01-3104722449core:OfficeEquipment2024-02-012025-01-3104722449core:NetGoodwill2024-02-012025-01-3104722449core:IntangibleAssetsOtherThanGoodwill2024-02-012025-01-3104722449core:ListedExchangeTraded2024-02-012025-01-3104722449core:UnlistedNon-exchangeTraded2024-02-012025-01-3104722449core:MoreThanFiveYears2024-02-012025-01-3104722449core:Non-currentFinancialInstruments2025-01-3104722449core:Non-currentFinancialInstruments2024-01-3104722449dpl:CostSales2024-02-012025-01-3104722449dpl:DistributionCosts2024-02-012025-01-3104722449core:LandBuildings2024-02-012025-01-3104722449core:PlantMachinery2024-02-012025-01-3104722449core:Vehicles2024-02-012025-01-3104722449core:FurnitureFittings2024-02-012025-01-3104722449core:OfficeEquipment2024-02-012025-01-3104722449dpl:AdministrativeExpenses2024-02-012025-01-3104722449core:NetGoodwill2024-02-012025-01-3104722449core:IntangibleAssetsOtherThanGoodwill2024-02-012025-01-3104722449dpl:GroupUndertakings2024-02-012025-01-3104722449dpl:ParticipatingInterests2024-02-012025-01-3104722449dpl:GroupUndertakingscore:ListedExchangeTraded2024-02-012025-01-3104722449core:ListedExchangeTraded2024-02-012025-01-3104722449dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-02-012025-01-3104722449core:UnlistedNon-exchangeTraded2024-02-012025-01-3104722449dpl:CostSales2023-07-012024-01-3104722449dpl:DistributionCosts2023-07-012024-01-3104722449core:LandBuildings2023-07-012024-01-3104722449core:PlantMachinery2023-07-012024-01-3104722449core:Vehicles2023-07-012024-01-3104722449core:FurnitureFittings2023-07-012024-01-3104722449core:OfficeEquipment2023-07-012024-01-3104722449dpl:AdministrativeExpenses2023-07-012024-01-3104722449core:NetGoodwill2023-07-012024-01-3104722449core:IntangibleAssetsOtherThanGoodwill2023-07-012024-01-3104722449dpl:GroupUndertakings2023-07-012024-01-3104722449dpl:ParticipatingInterests2023-07-012024-01-3104722449dpl:GroupUndertakingscore:ListedExchangeTraded2023-07-012024-01-3104722449core:ListedExchangeTraded2023-07-012024-01-3104722449dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-07-012024-01-3104722449core:UnlistedNon-exchangeTraded2023-07-012024-01-3104722449core:NetGoodwill2025-01-3104722449core:IntangibleAssetsOtherThanGoodwill2025-01-3104722449core:LandBuildings2025-01-3104722449core:PlantMachinery2025-01-3104722449core:Vehicles2025-01-3104722449core:FurnitureFittings2025-01-3104722449core:OfficeEquipment2025-01-3104722449core:AfterOneYear2025-01-3104722449core:WithinOneYear2025-01-3104722449core:ListedExchangeTraded2025-01-3104722449core:UnlistedNon-exchangeTraded2025-01-3104722449core:ShareCapital2025-01-3104722449core:SharePremium2025-01-3104722449core:RevaluationReserve2025-01-3104722449core:OtherReservesSubtotal2025-01-3104722449core:RetainedEarningsAccumulatedLosses2025-01-3104722449core:NetGoodwill2024-01-3104722449core:IntangibleAssetsOtherThanGoodwill2024-01-3104722449core:LandBuildings2024-01-3104722449core:PlantMachinery2024-01-3104722449core:Vehicles2024-01-3104722449core:FurnitureFittings2024-01-3104722449core:OfficeEquipment2024-01-3104722449core:AfterOneYear2024-01-3104722449core:WithinOneYear2024-01-3104722449core:ListedExchangeTraded2024-01-3104722449core:UnlistedNon-exchangeTraded2024-01-3104722449core:ShareCapital2024-01-3104722449core:SharePremium2024-01-3104722449core:RevaluationReserve2024-01-3104722449core:OtherReservesSubtotal2024-01-3104722449core:RetainedEarningsAccumulatedLosses2024-01-3104722449core:NetGoodwill2023-07-0104722449core:IntangibleAssetsOtherThanGoodwill2023-07-0104722449core:LandBuildings2023-07-0104722449core:PlantMachinery2023-07-0104722449core:Vehicles2023-07-0104722449core:FurnitureFittings2023-07-0104722449core:OfficeEquipment2023-07-0104722449core:AfterOneYear2023-07-0104722449core:WithinOneYear2023-07-0104722449core:ListedExchangeTraded2023-07-0104722449core:UnlistedNon-exchangeTraded2023-07-0104722449core:ShareCapital2023-07-0104722449core:SharePremium2023-07-0104722449core:RevaluationReserve2023-07-0104722449core:OtherReservesSubtotal2023-07-0104722449core:RetainedEarningsAccumulatedLosses2023-07-0104722449core:AfterOneYear2024-02-012025-01-3104722449core:WithinOneYear2024-02-012025-01-3104722449core:Non-currentFinancialInstrumentscore:CostValuation2024-02-012025-01-3104722449core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-012025-01-3104722449core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-012025-01-3104722449core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-012025-01-3104722449core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-012025-01-3104722449core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-012025-01-3104722449core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-012025-01-3104722449core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-012025-01-3104722449core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-012025-01-3104722449core:Non-currentFinancialInstrumentscore:CostValuation2025-01-3104722449core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-3104722449core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-3104722449core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-3104722449core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-3104722449core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-3104722449core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-3104722449core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-3104722449core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-3104722449core:Non-currentFinancialInstrumentscore:CostValuation2024-01-3104722449core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-3104722449core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-3104722449core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-3104722449core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-3104722449core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-3104722449core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-3104722449core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-3104722449core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-3104722449bus:Director12024-02-012025-01-3104722449bus:Director22024-02-012025-01-31

WICKHAM MARKET MEDICAL CENTRE LTD.

Registered Number
04722449
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2025

WICKHAM MARKET MEDICAL CENTRE LTD.
Company Information
for the year from 1 February 2024 to 31 January 2025

Directors

LEE, Wei Vern
LOH, Jo Nyee

Registered Address

Acer Road Pharmacy 6 Acer Road
Rendlesham
Woodbridge
IP12 2GA

Registered Number

04722449 (England and Wales)
WICKHAM MARKET MEDICAL CENTRE LTD.
Balance Sheet as at
31 January 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets32,6661,666
2,6661,666
Current assets
Stocks421,17732,873
Debtors585,76885,353
Cash at bank and on hand88,56259,142
195,507177,368
Creditors amounts falling due within one year6(106,428)(103,978)
Net current assets (liabilities)89,07973,390
Total assets less current liabilities91,74575,056
Creditors amounts falling due after one year7(3,412)-
Provisions for liabilities(667)-
Net assets87,66675,056
Capital and reserves
Called up share capital1010
Profit and loss account87,65675,046
Shareholders' funds87,66675,056
The financial statements were approved and authorised for issue by the Board of Directors on 1 May 2025, and are signed on its behalf by:
LEE, Wei Vern
Director
Registered Company No. 04722449
WICKHAM MARKET MEDICAL CENTRE LTD.
Notes to the Financial Statements
for the year ended 31 January 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Operating leases
Where, substantially, all the risks and rewards of ownership of the asset do not transfer from the lessor to the company, the lease is treated as an operating lease. Rentals payable under operating leases are charged to the profit and loss account on a straight-line basis over the period of the lease.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Plant and machinery20
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2.Average number of employees

20252024
Average number of employees during the year78
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 February 244,715
Additions1,251
At 31 January 255,966
Depreciation and impairment
At 01 February 243,049
Charge for year251
At 31 January 253,299
Net book value
At 31 January 252,666
At 31 January 241,666
4.Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition. Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential. At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss

2025

2024

££
Finished goods21,17732,873
Total21,17732,873
5.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables77,04064,889
Other debtors7,98919,649
Prepayments and accrued income739815
Total85,76885,353
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables75,44898,854
Taxation and social security29,703-
Other creditors-5,124
Accrued liabilities and deferred income1,277-
Total106,428103,978
7.Creditors: amounts due after one year

2025

2024

££
Amounts owed to related parties3,412-
Total3,412-
8.Secured creditors
The company’s assets are subject to both fixed and floating charges in connection with borrowings taken out by the parent company, Jovern Ltd, for the acquisition of the subsidiary. The fixed charge applies to certain assets of the company. The floating charge applies to all present and future assets of the company. These charges were registered at Companies House in February 2024 and secure the parent company’s loan
9.Share capital
The company has an issued share capital of £10, divided into 10 ordinary shares of £1 each, all of which are fully paid. Ordinary shares have full rights in the company with respect to voting, dividends and distribution.
10.Related party transactions
The company has received management services from its parent company, Jovern Ltd, for the year. The charges total £24,000 (2024: £0). The company owed Jovern Ltd £3,412 (2024: £0 at the balance sheet date, which is included in amounts owed to group undertakings (Non-current).
11.Parent-subsidiary relationships
Jovern Ltd, a company registered in England & Wales, is the immediate parent company by virtue of ownership of 100% of issued share capital.